drugset / Trial / NCT02932488
Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to show that PET-MR imaging can be used for obtaining a pharmacodynamic profile of drugs. By using the 5-HT1B receptor as target we also aim to find effect areas and sizes of the 5-HT1B receptor agonist sumatriptan.
Timeline
- Start
- 2016-09
- Primary completion
- 2019-06
- Completion
- 2019-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sumatriptan | Unknown | 10 ug/kg | — |
| Subject | Sumatriptan | Unknown | 80 ug/kg | — |
Indications
No indication recorded.